Michael S. Pilo

Michael focuses his practice on capital markets transactions across sectors, specializing in life sciences (e.g., biotech, biopharma, medtech, healthcare), technology and crypto companies. Michael regularly represents issuers and investment banks in all manner of public and private capital raising events, including IPOs, follow-ons, high-yield bond offerings, private placements, ATMs, convertible debt and deSPAC business combinations. He also regularly counsels public companies, their advisors and boards of directors on securities law compliance, corporate governance practices and disclosure.

Prior to joining Baker McKenzie, Michael advised on the following matters:**

Equity Offerings

• BioAge, a biopharma company targeting the biology of human aging, USD 238 million IPO, USD 11 million concurrent private placement and USD 75 million ATM offering.**
• BitGo, a digital asset custody and infrastructure company, USD 213 million IPO.**
• Informatica*, a cloud data management tech company, USD 841 million IPO and USD 408 million follow-on offering.**

Debt Offerings

• Change Healthcare, a healthcare technology platform company, US 1.2 billion 144A senior notes offering.**
• Karyopharm Therapeutics,* a pharmaceutical company, USD 150 million convertible senior notes offering.**
• Surgery Partners, a healthcare services company, aggregate of USD 770 million senior unsecured notes offering.**

M&A Transactions

• Resulticks, an AI-driven customer engagement platform, acquisition by Diginex for USD 1.5 billion in an all-share transaction (closing pending).
• Servier, an independent international pharmaceutical group, USD 2.5 billion tender offer of all shares of common stock of Day One Biopharmaceuticals.
• Nextdoor, a social network tech company, deSPAC business combination with Khosla Ventures Acquisition Co. II.**

SPAC IPOs

• Altimeter Growth I’s (Grab) USD 450 million IPO.**
• Altimeter Growth II’s USD 450 million IPO.**
• Ares Acquisition’s* USD 870 million IPO.**

* Representing the Representatives on behalf of the Underwriters/Initial Purchasers/Placements Agents, including for such investment banks as Goldman Sachs, Morgan Stanley, J.P. Morgan, Barclays, BofA Securities, Citigroup, Leerink, TD Cowen, Jefferies, Deutsche Bank, Evercore, UBS, Guggenheim, and Cantor among others.

• Listed, The Legal 500, US Capital Markets: Equity Offerings, 2022-2023